Find a Tender
complete
Official procurement procedure
Primary human cells for Organ-on-chip studies
Laboratory reagents
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency: "Primary human cells for Organ-on-chip studies". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
1.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 125 active published awards; 77 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published24 Jul 2024, 16:03 BST | Last source update24 Jul 2024, 16:03 BST | Recurring procurementNot published |
ClassificationLaboratory reagents | ||
Delivery area UK | ||
OCIDocds-h6vhtk-048446 | ||
What is being bought
This VEAT notice indicates that the UK Health Security Agency (UKHSA) intends to directly award a contract to Lonza Group UK Ltd for the purchase of HLA-typed human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L), and human immune cells (PBMC) over a three-year period.
What changed
From the official release history
- Status changed to complete
24 Jul 2024, 16:03 BST - Official notice release published
24 Jul 2024, 16:03 BST - Buyer information updated
24 Jul 2024, 16:03 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedStatus not publishedPublished valueNot publishedUKHSA requires to purchase HLA typed matching human small airway epithelial cells (SAEC), lung microvascular endothelial cells (HMVEC-L) and human immune cells (PMBC) over a 3-year period. Cells will be used in an established human Lung on a Chip (LoC) system at Porton Down. In order that LoC platforms can generate the most representative models of human organs, cells harvested directly from recently deceased, healthy humans are required (primary human cells). UKHSA believes that the only supplier that has a large enough clinical network underpinning their catalogue to maximise availability of donors to UKHSA (and the critical donor information including HLA type) is Lonza Group. Supply of these specific cells are limited. While suppliers/re-sellers of some cell types could be found, the requirement for having SAEC and MVEC from the same donor along with a large bank of Peripheral blood mononuclear cells (PBMC) donors in order to maximise compatibility excluded the majority of the small operations and re-sellers. Therefore, a decision has been made to enter into a 3-year agreement with Lonza Group for this procurement with 12-month extension option available.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
24 Jul 2024, 16:03 BST - Award active
Not published · Not published - Contract active
Signed 4 Jul 2024, 00:00 BST · Not published
Commercial outcome and competition
Awards Awarded supplier not published Not published · Not published · active |
Contracts Contract Not published · signed 4 Jul 2024, 00:00 BST · active |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency
Contracting authority GB-FTS-91907Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleCompetition is absent for technical reasons. |